Form 144: Essent Group (ESNT) plans to sell 22,370 common shares valued $1.52M
Rhea-AI Filing Summary
Essent Group Ltd (ESNT) Form 144 notifies a proposed sale of 22,370 common shares with an aggregate market value of $1,520,511.00, against 98,533,757 shares outstanding, with an approximate sale date of 08/12/2025 on the NYSE. The filing shows the securities were acquired on 01/01/2016 as a stock grant and lists The Charles Schwab Corporation as the broker. Recent reported sales in the past three months list 1,999 shares sold on 06/23/2025 for $119,947 and 240 shares sold on 07/01/2025 for $14,880. The form includes the standard Rule 144 representations; the filing does not explicitly name the person for whose account the current notice is filed.
Positive
- None.
Negative
- None.
Insights
TL;DR: The filing documents a modest proposed insider sale of 22,370 ESNT shares; size appears immaterial relative to outstanding stock.
The proposed sale equals 22,370 shares, or roughly 0.023% of the 98,533,757 shares outstanding, indicating the transaction is small in relation to total equity. The filing also discloses two recent small disposals totaling 2,239 shares and combined proceeds of $134,827, which suggests routine liquidity events rather than a material shift in ownership. No earnings or covenant changes are reported.
TL;DR: Form 144 provides required Rule 144 disclosure: acquisition details, broker, and recent sales; it includes standard seller representations.
The form lists the acquisition date (01/01/2016) and nature (stock grant), identifies the broker (The Charles Schwab Corporation), and records prior sales by Mary L Gibbons in June and July 2025. The document contains the statutory attestation about material nonpublic information and references plan/adoption date fields, which are not populated. From a compliance perspective, the filing records the key items Rule 144 requires but does not provide additional trading-plan details.
FAQ
What does the Form 144 for Essent Group (ESNT) report?
How many ESNT shares are proposed to be sold and what is their aggregate value?
When and how were the securities being sold originally acquired?
Were any ESNT shares sold recently by the filer or related person?
Which broker is listed for the proposed sale in the ESNT Form 144?
Does the filing identify the person for whose account the sale is to be made?